MITRAFIT- Cardinal Adjustable Mitral Repair Follow-up International Postmarketing Surveillance (PMS)

NCT01617720 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2021-11-05

No results posted yet for this study

Summary

This Study is designed to observe the clinical outcomes of patients requiring mitral repair that were treated with the CE certified Cardinal System.

Conditions

  • Mitral Regurgitation

Sponsors & Collaborators

  • Edwards Lifesciences

    lead INDUSTRY

Principal Investigators

  • Ottavio Alfieri, Prof, MD · Hospital San Raffaele, Milan, Italy

  • Nicolas Doll, Prof, MD · SANA Herzchirurgie Stuttgart , Germany

  • Ehud Raanani, Prof, MD · Sheba Medical Center

  • Patrik Nataf, Prof, MD · Bichat Hospital, Paris, France

  • Volkmar Falk, Prof, MD · Zurich University, Zurich, Switzerland

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Germany
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01617720 on ClinicalTrials.gov